Related content

Roles of adiponectin and oxidative stress in obesity-associated metabolic and cardiovascular diseases

By Matsuda Morihiro   Shimomura Iichiro  

Reviews in Endocrine and Metabolic Disorders, Vol. 15, Iss. 1, 2014-03 ,pp. : 1-10

Springer Publishing Company

Access to resources Recommend Favorite

Sex Steroid Hormones, Cardiovascular Diseases and The Metabolic Syndrome

By  

Cardiovascular & Hematological Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Cardiovascular & Hematological Agents), Vol. 9, Iss. 3, 2011-07 ,pp. : 137-146

Bentham Science Publishers

Access to resources Recommend Favorite

Serum levels of the senescence biomarker clusterin/apolipoprotein J increase significantly in diabetes type II and during development of coronary heart disease or at myocardial infarction

By Trougakos I.P.   Poulakou M.   Stathatos M.   Chalikia A.   Melidonis A.   Gonos E.S.  

Experimental Gerontology, Vol. 37, Iss. 10, 2002-10 ,pp. : 1175-1187

Elsevier

Access to resources Recommend Favorite

A Review of Sirt1 and Sirt1 Modulators in Cardiovascular and Metabolic Diseases

By  

Recent Patents on Cardiovascular Drug Discovery, Vol. 3, Iss. 3, 2008-11 ,pp. : 156-164

Bentham Science Publishers

Access to resources Recommend Favorite

Is being first-born another risk factor for metabolic and cardiovascular diseases?

By Ayyavoo Ahila   Derraik José GB   Hofman Paul L   Cutfield Wayne S  

Future Cardiology, Vol. 9, Iss. 4, 2013-07 ,pp. : 447-450

Future Medicine

Access to resources Recommend Favorite